LPL Financial LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 198 filers reported holding PDL BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is 1.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
LPL Financial LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2018$123,000
+17.1%
41,864
+9.7%
0.00%
Q4 2017$105,000
-67.0%
38,169
-59.4%
0.00%
-100.0%
Q3 2017$318,000
+34.2%
93,902
-2.3%
0.00%0.0%
Q2 2017$237,000
+4.4%
96,107
-2.5%
0.00%
-50.0%
Q1 2017$227,000
+0.4%
98,534
-2.6%
0.00%0.0%
Q4 2016$226,000
-53.3%
101,187
-31.6%
0.00%
-60.0%
Q3 2016$484,000
-6.2%
148,038
-8.9%
0.01%
+25.0%
Q2 2016$516,000
-49.6%
162,415
-47.5%
0.00%
+33.3%
Q1 2016$1,024,000
+29.1%
309,280
+34.9%
0.00%
+50.0%
Q4 2015$793,000
+0.4%
229,313
+51.8%
0.00%
-50.0%
Q3 2015$790,000
-7.7%
151,020
+9.0%
0.00%0.0%
Q2 2015$856,000
-6.9%
138,553
+8.0%
0.00%
-20.0%
Q1 2015$919,000
+77.8%
128,241
+91.2%
0.01%
+66.7%
Q4 2014$517,000
-9.1%
67,066
-11.5%
0.00%0.0%
Q3 2014$569,000
-58.1%
75,792
-45.9%
0.00%
-62.5%
Q2 2014$1,357,000
+16.6%
140,144
+0.0%
0.01%
+14.3%
Q1 2014$1,164,000
-2.8%
140,112
-1.3%
0.01%0.0%
Q4 2013$1,198,000
+29.0%
141,993
+22.7%
0.01%
+16.7%
Q3 2013$929,000
+43.6%
115,705
+38.1%
0.01%
+20.0%
Q2 2013$647,00083,8080.01%
Other shareholders
PDL BIOPHARMA INC shareholders Q1 2016
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders